Toll free

18002022232

Global Scientific Development in Advanced Cancer Therapies

CAR T - cell Therapy

Uses a patient's immune or donor cells to fight cancer by modifying them to recognize and attack cancerous cells.
Learn more

TIL Therapy

Collects and grows special white blood cells from tumors, then reinfuses them to attack cancer cells.
Learn more

TCR Therapy

Modifies T-cells to recognize and target cancer cells more effectively through advanced immunotherapy techniques.
Learn more

Bone Marrow Transplantation

Replaces damaged or diseased bone marrow by transplanting healthy stem cells into the patient's body.
Learn more

Immunotherapy

Uses the body's immune system to find and destroy cancer cells through targeted immune response activation.
Learn more

Targeted Therapy

Uses specialized drugs to target specific genes or proteins that help cancer cells grow, divide, and spread while limiting harm to healthy cells.
Learn more

Chemotherapy

Uses powerful drugs to kill fast-growing cancer cells throughout the body with systemic treatment approach.
Learn more

Pediatric Services

Provides advanced treatments for pediatric disorders such as thalassaemia, hemophilia, sickle cell anemia, nutritional anemia and cancers in children.
Learn more
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct genitourinary cancer case study on GPC3-targeted CAR T therapy for refractory non-seminomatous germ cell tumor
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct colon cancer case study highlighting TCR-based approach in metastatic colon cancer with lung lesions
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct breast cancer case study showcasing HER2-positive treatment with CAR T-cell therapy
SunAct head and neck cancer case study using TCR-p53 therapy in inoperable squamous cell carcinoma
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct case study featuring gamma delta T-cell therapy for recurrent tongue carcinoma with extensive metastasis
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct head and neck cancer case study on salivary ductal carcinoma managed with advanced therapies
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct case study on GD2-targeted CAR T therapy for diffuse midline glioma in a 22-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male
SunAct CNS case study on GBM treatment using multiple gene mutation targeting in a 36-year-old male